comprehensive -WSS

comprehensive

author：hotspot 2025-09-27 22:49:38 - browse：43538

Photo illustration of Covid 19 testing swabs on a blue background. — Timothy Stenzel led the FDA's diagnostics division during the Covid-19 pandemic, as the agency scrambled to push through and validate accurate Covid tests. Adobe

Timothy Stenzel, the federal regulator who led the Food and Drug Administration’s diagnostics division during the chaotic time of Covid-19 pandemic, has left the agency. The FDA confirmed Thursday that Stenzel, who led the FDA’s office of in vitro diagnostics, retired at the end of 2023.

During the early days of the pandemic, Stenzel was in the middle of a turf battle between the Centers for Disease Control and Prevention and the FDA over the regulation of Covid tests. At one point, the CDC made Stenzel wait at its facility overnight after he arrived for a meeting on Covid test development, Politico reported at the time.

It was a hectic time. Testmakers rapidly introduced new Covid-19 screening products with little data, as it was a brand new virus. The pandemic especially laid bare FDA’s inability to control lab-developed tests (LDTs). Many of the Covid-19 PCR tests fell in this category. Early on, using powers granted by the public health emergency, the FDA required labs to apply for emergency use authorization. But a STAT investigation found that the Department of Health and Human Services told the FDA to stop this measure, despite knowing that many of the tests may have been inaccurate.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： Senator probes 340B programs at Cleveland Clinic, Bon Secours

hotspot

WSS

FDA seeks to regulate lab

Sudafed saga points to U.S. issues with evaluating older drugs

Readout LOUD podcast: mifepristone case, GLP

Ionis has late

Eliminate the waiting period for sterilization covered by Medicaid

WHO recommends dropping component of many flu vaccines

explore

comprehensive

leisure time

Medicare proposal to cover medical devices draws a mixed reaction

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Anesthesiologist group: stop taking Ozempic before surgery

Merck drug for rare lung condition set for approval in U.S.

Hollywood unions extend contract negotiations for actors

Donor acceptance rates hint at racial, gender bias in heart transplants: study

Bright Health sells Medicare Advantage business to Molina

Primary care physicians play key roles in Alzheimer's management

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Kaiser Permanente unions announce official strike date

entertainment

There's no autism epidemic. It's an autism diagnosis epidemic

Oprah kicked off a national conversation on obesity. Let's have it

Why do women spend more than men on medical expenses?

Why the world’s most expensive drug might be worth the price

Abortion pill case raises question: who can sue the FDA?

Why do women spend more than men on medical expenses?

explore

entertainment

hotspot

focus